Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.71)
# 1,901
Out of 4,784 analysts
10
Total ratings
62.5%
Success rate
17.03%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Initiates: Buy | $31 | $11.71 | +164.73% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $7.31 | +47.74% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $2.90 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $2.41 | +2,597.10% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $35.29 | +47.35% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $130.67 | -0.51% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $210.47 | -38.23% | 3 | May 21, 2020 |
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $11.71
Upside: +164.73%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $7.31
Upside: +47.74%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.90
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $2.41
Upside: +2,597.10%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $35.29
Upside: +47.35%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $130.67
Upside: -0.51%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $210.47
Upside: -38.23%